medication in a clinical specimen. 5-Fluorocytosine, amikacin, chloramphenicol, dibekacin, ethambutol, fluconazole, gentamicin, itraconazole, isepamicin, kanamycin, ketoconazole, netilmycin, sisomycin, streptomycin, teicoplanin, tobramycin, vancomycin, voriconazole. L3CT CT865 Anti-neoplastic (Class therapeutic drug monitoring 3 IVDs IVDs) IVDs that are intended to be used in therapeutic monitoring of anti-neoplastic drugs in a clinical specimen. Methotrexate. L3CT CT861 Cardiovascular (Class therapeutic drug monitoring 3 IVDs IVDs) IVDs that are intended to be used in therapeutic monitoring of cardiovascular drugs in a clinical specimen. Digitoxin, digoxin, disopyramide, flecainide, lidocaine, mexiletine, procainamide, propanolol, quinidine. L3CT CT862 Central nervous system therapeutic 3 monitoring IVDs IVDs) IVDs that are intended to be used in therapeutic monitoring of drugs targeting the central nervous system in a clinical specimen. Amoxapine, carbamazepine, chlorpromazine, clomipramine/norclomipramine, desipramine, escitalopram, ethosuximide, haloperidol (haldol), hydroxyzine chloride (atarax), imipramine, lithium, methsuximide, phenobarbital, phenothiazine, phenytoin (dilantin), primidone, valproic acid, zonisamide. L3CT CT866 Immunosuppressant (Class therapeutic drug monitoring 3 IVDs IVDs) IVDs that are intended to be used in therapeutic monitoring of drugs targeting the immune system in a clinical specimen. Cyclosporin A/cyclosporine, mycophenolate (Cellsept), rapamycin (sirolimus), tacrolimus. CT184 Clinical chemistry toxicology/drug detection IVDs IVDs that are intended to be used for the qualitative and/or quantitative
medication in a clinical specimen. 5-Fluorocytosine, amikacin, chloramphenicol, dibekacin, ethambutol, fluconazole, gentamicin, itraconazole, isepamicin, kanamycin, ketoconazole, netilmycin, sisomycin, streptomycin, teicoplanin, tobramycin, vancomycin, voriconazole. L3CT (Class 3 IVDs) CT865 Anti-neoplastic therapeutic drug monitoring IVDs IVDs that are intended to be used in therapeutic monitoring of anti-neoplastic drugs in a clinical specimen. Methotrexate. L3CT (Class 3 IVDs) CT861 Cardiovascular therapeutic drug monitoring IVDs IVDs that are intended to be used in therapeutic monitoring of cardiovascular drugs in a clinical specimen. Digitoxin, digoxin, disopyramide, flecainide, lidocaine, mexiletine, procainamide, propanolol, quinidine. L3CT 3 IVDs) CT862 Central nervous system therapeutic monitoring IVDs IVDs that are intended to be used in therapeutic monitoring of drugs targeting the central nervous system in a clinical specimen. Amoxapine, carbamazepine, chlorpromazine, clomipramine/norclomipramine, desipramine, escitalopram, ethosuximide, haloperidol (haldol), hydroxyzine chloride (atarax), imipramine, lithium, methsuximide, phenobarbital, phenothiazine, phenytoin (dilantin), primidone, valproic acid, zonisamide. L3CT (Class 3 IVDs) CT866 Immunosuppressant therapeutic drug monitoring IVDs IVDs that are intended to be used in therapeutic monitoring of drugs targeting the immune system in a clinical specimen. Cyclosporin A/cyclosporine, mycophenolate (Cellsept), rapamycin (sirolimus), tacrolimus. CT184 Clinical chemistry toxicology/drug detection IVDs IVDs that are intended to be used for the qualitative and/or quantitative